Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Deguchi

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Oncology|March 10, 2006
Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinomaKazutaka Kurokohchi, Tsutomu Masaki, Seishiro Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2022
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinomaTetsu Tomonari, Joji Tani, Chikara Ogawa, et al.
International Journal of Molecular Medicine|August 15, 2014
Profile of microRNAs associated with aging in rat liverShima Mimura, Hisakazu Iwama, Kiyohito Kato, et al.
Cancers|June 2, 2021
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) StudyJoji Tani, Tomonori Senoh, Akio Moriya, et al.
International Journal of Oncology|February 11, 2005
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liverTsutomu Masaki, Masaaki Tokuda, Shuhei Yoshida, et al.
Oncology Reports|September 9, 2011
Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survivalAsahiro Morishita, Jian Gong, Akihiro Deguchi, et al.
Journal of Gastroenterology and Hepatology|August 26, 2020
Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapiesHirohito Yoneyama, Asahiro Morishita, Hisakazu Iwama, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinomaShi Liu, Jian Gong, Asahiro Morishita, et al.
Molecular and Clinical Oncology|October 12, 2019
Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasionTakako Nomura, Joji Tani, Akihiro Deguchi, et al.
Oncology Letters|March 21, 2020
Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group StudyJoji Tani, Asahiro Morishita, Teppei Sakamoto, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Oncology|March 10, 2006
Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinomaKazutaka Kurokohchi, Tsutomu Masaki, Seishiro Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2022
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinomaTetsu Tomonari, Joji Tani, Chikara Ogawa, et al.
International Journal of Molecular Medicine|August 15, 2014
Profile of microRNAs associated with aging in rat liverShima Mimura, Hisakazu Iwama, Kiyohito Kato, et al.
Cancers|June 2, 2021
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) StudyJoji Tani, Tomonori Senoh, Akio Moriya, et al.
International Journal of Oncology|February 11, 2005
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liverTsutomu Masaki, Masaaki Tokuda, Shuhei Yoshida, et al.
Oncology Reports|September 9, 2011
Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survivalAsahiro Morishita, Jian Gong, Akihiro Deguchi, et al.
Journal of Gastroenterology and Hepatology|August 26, 2020
Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapiesHirohito Yoneyama, Asahiro Morishita, Hisakazu Iwama, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinomaShi Liu, Jian Gong, Asahiro Morishita, et al.
Molecular and Clinical Oncology|October 12, 2019
Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasionTakako Nomura, Joji Tani, Akihiro Deguchi, et al.
Oncology Letters|March 21, 2020
Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group StudyJoji Tani, Asahiro Morishita, Teppei Sakamoto, et al.
Pageof 6